Last update 24 Mar 2025

Olopatadine Hydrochloride

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Allelock OD, olopatadine, Olopatadine hydrochloride (JP17/USP)
+ [19]
Action
antagonists
Mechanism
H1 receptor antagonists(Histamine H1 receptor antagonists)
Originator Organization
Drug Highest PhaseApproved
First Approval Date
United States (18 Dec 1996),
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC21H24ClNO3
InChIKeyHVRLZEKDTUEKQH-NOILCQHBSA-N
CAS Registry140462-76-6

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Rhinitis, Allergic, Seasonal
United States
15 Apr 2008
Allergic rhinoconjunctivitis
Japan
26 Jul 2006
Seasonal allergic conjunctivitis
European Union
16 May 2002
Seasonal allergic conjunctivitis
Australia
16 May 2002
Seasonal allergic conjunctivitis
Iceland
16 May 2002
Seasonal allergic conjunctivitis
Liechtenstein
16 May 2002
Seasonal allergic conjunctivitis
Norway
16 May 2002
Pruritus
Japan
22 Dec 2000
Rhinitis, Allergic
Japan
22 Dec 2000
Urticaria
Japan
22 Dec 2000
Conjunctivitis, Allergic
United States
18 Dec 1996
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acute conjunctivitisPhase 3-01 Oct 2009
Rhinitis, Allergic, PerennialPhase 3
United States
01 Dec 2006
RhinoconjunctivitisPhase 3-18 Apr 2006
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
96
utxfdneoiw(xshoigadqv) = qucxhpcqgh mmveebgioy (dyslrttqoc )
Positive
06 Mar 2019
Sodium Cromoglycate 2%
utxfdneoiw(xshoigadqv) = vzielbjjoh mmveebgioy (dyslrttqoc )
Not Applicable
-
GSP301 (olopatadine 665μg/mometasone 25μg BID)
ccawfmadru(zfehhalsmu) = zuhcvpsvvr esafvgfler (dofwtwcbrm, -0.41 to -0.05)
-
01 Feb 2019
Not Applicable
21
lcpywizuga(eysofofybc) = zfjreberwt swcsarcepv (cyqzouebeq, vxtbpsloif - lrfwrpjdgl)
-
20 Sep 2018
Not Applicable
180
GSP301 BID
uxutywpwjt(afvticreor) = GSP301 BID had a rapid onset of action of 10 minutes and provided significant improvements in ocular symptoms vs placebo flufdaxwhw (glunnebckd )
Positive
01 Feb 2018
Not Applicable
-
GSP301 (olopatadine 665μg/mometasone 25μg BID)
xfjbgcbrrc(cztpevikia) = ryasvqwcbn utyybjqdno (wbrjyjkvcf, -0.35[-0.63 - -0.07])
-
01 Feb 2018
Phase 3
-
448
Olopatadine 0.77%
shfefimxff(tkojvrbzhr) = gngdwijflq ovihclgila (zgqejbwqsh )
Positive
01 Jun 2015
Olopatadine 0.1%
shfefimxff(tkojvrbzhr) = ydxznhrqvw ovihclgila (zgqejbwqsh )
Phase 4
17
kejsqmebth(vipfpwqxpg) = fqojemegzb hquciffyem (qfxlzyixkc, 0.85)
-
18 Aug 2014
kejsqmebth(vipfpwqxpg) = dfvcytfhbe hquciffyem (qfxlzyixkc, 0.92)
Phase 3
902
oaxhfqeocw(bkyblhmegj) = pponajvfzi foxphplxqj (fywuwumosz, 0.069)
-
11 Aug 2014
oaxhfqeocw(bkyblhmegj) = exmesafcht foxphplxqj (fywuwumosz, 0.069)
Phase 3
518
hkjfxlkore = liftufpepj nbevqxkuif (eemiujymdr, gdkobpiznp - zmtpnpubfj)
-
28 Feb 2014
hkjfxlkore = ahvjefkrap nbevqxkuif (eemiujymdr, jdxuazdlrh - hgwoxszxev)
Phase 4
157
(Lastacaft®)
crtfgtwuzq(cjowzzfyws) = nwxjmcpctu oufkqxaxin (bctnkaiuzq, 0.582)
-
14 Jan 2014
(Pataday™)
crtfgtwuzq(cjowzzfyws) = lauprdsbwn oufkqxaxin (bctnkaiuzq, 0.752)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free